A Review of Digital Interventions to Decrease Cannabis Use Among Patients With Comorbid Psychiatric Disorders

References

• Addington, J., & Addington, D. (2001). Impact of an early psychosis program on substance use. Psychiatric Rehabilitation Journal, 25(1), 60–67. https://doi.org/10.1037/h0095049
   PubMed Web of Science ®Google Scholar
• Aydin, C., Tibbo, P. G., & Ursuliak, Z. (2016). Psychosocial interventions in reducing cannabis use in early phase psychosis: A Canadian survey of treatments offered. Canadian Journal of Psychiatry. Revue canadienne de psychiatrie, 61(6), 367–372. https://doi.org/10.1177/0706743716639931
   PubMed Web of Science ®Google Scholar
• Baker, A. L., Thornton, L. K., Hides, L., & Dunlop, A. (2012). Treatment of cannabis use among people with psychotic disorders: A critical review of randomised controlled trials. Current Pharmaceutical Design, 18(32), 4923–4937. https://doi.org/10.2174/138161212802884834
   PubMed Web of Science ®Google Scholar
• Barrowclough, C., Marshall, M., Gregg, L., Fitzsimmons, M., Tomenson, B., Warburton, J., & Lobban, F. (2014). A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: A randomized controlled trial. Psychological Medicine, 44(13), 2749–2761. https://doi.org/10.1017/S0033291714000208
   PubMed Web of Science ®Google Scholar
• Bland, R. C., Newman, S. C., & Orn, H. (1997). Help-seeking for psychiatric disorders. The Canadian Journal of Psychiatry, 42(9), 935–942. https://doi.org/10.1177/070674379704200904
   PubMed Web of Science ®Google Scholar
• Bonomo, Y., Souza, J. D. S., Jackson, A., Crippa, J. A. S., & Solowij, N. (2018). Clinical issues in cannabis use. British Journal of Clinical Pharmacology, 84(11), 2495–2498. https://doi.org/10.1111/bcp.13703
   PubMed Web of Science ®Google Scholar
• Boumparis, N., Loheide-Niesmann, L., Blankers, M., Ebert, D. D., Korf, D., Schaub, M. P., Spijkerman, R., Tait, R. J., & Riper, H. (2019). Short- and long-term effects of digital prevention and treatment interventions for cannabis use reduction: A systematic review and meta-analysis. Drug and Alcohol Dependence, 200, 82–94. https://doi.org/10.1016/j.drugalcdep.2019.03.016
   PubMed Web of Science ®Google Scholar
• Brown, L. K., Nugent, N. R., Houck, C. D., Lescano, C. M., Whiteley, L. B., Barker, D., Viau, L., & Zlotnick, C. (2011). Safe Thinking and Affect Regulation (STAR): Human immunodeficiency virus prevention in alternative/therapeutic schools. Journal of the American Academy of Child & Adolescent Psychiatry, 50(10), 1065–1074. https://doi.org/10.1016/j.jaac.2011.06.018
   PubMed Web of Science ®Google Scholar
• Carr, J. A. R., Norman, R. M. G., & Manchanda, R. (2009). Substance misuse over the first 18 months of specialized intervention for first episode psychosis. Early Intervention in Psychiatry, 3(3), 221–225. https://doi.org/10.1111/j.1751-7893.2009.00136.x
   PubMed Web of Science ®Google Scholar
• Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., Poulton, R., & Craig, I. W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57(10), 1117–1127. https://doi.org/10.1016/j.biopsych.2005.01.026
   PubMed Web of Science ®Google Scholar
• DeMarce, J. M., Lash, S. J., Stephens, R. S., Grambow, S. C., & Burden, J. L. (2008). Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment. Addictive Behaviors, 33(9), 1104–1112. https://doi.org/10.1016/j.addbeh.2008.02.008
   PubMed Web of Science ®Google Scholar
• Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., La Barbera, D., Tarricone, I., Berardi, D., Szöke, A., Arango, C., Tortelli, A., Velthorst, E., Bernardo, M., Del-Ben, C. M., … van der Ven, E. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): A multicentre case-control study. The Lancet Psychiatry, 6(5), 427–436. https://doi.org/10.1016/S2215-0366(19)30048-3
   PubMed Web of Science ®Google Scholar
• Diehl, A., Cordeiro, D. C., & Laranjeira, R. (2010). Abuso de cannabis em pacientes com transtornos psiquiatricos: atualizacao para uma antiga evidencia [Cannabis abuse in patients with psychiatric disorders: An update to old evidence]. Revista Brasileira de Psiquiatria, 32(Suppl. 1), 541–545. https://doi.org/10.1590/S1516-44462010000500007
   Google Scholar
• Ducharme, L. J., Chandler, R. K., & Harris, A. H. S. (2016). Implementing effective substance abuse treatments in general medical settings: Mapping the research terrain. Journal of Substance Abuse Treatment, 60, 110–118. https://doi.org/10.1016/j.jsat.2015.06.020
   PubMed Web of Science ®Google Scholar
• Eack, S. M., Hogarty, S. S., Bangalore, S. S., Keshavan, M. S., & Cornelius, J. R. (2016). Patterns of substance use during Cognitive Enhancement Therapy: An 18-month randomized feasibility study. Journal of Dual Diagnosis, 12(1), 74–82. https://doi.org/10.1080/15504263.2016.1145778
   PubMed Web of Science ®Google Scholar
• Eack, S. M., Hogarty, S. S., Greenwald, D. P., Litschge, M. Y., McKnight, S. A. F., Bangalore, S. S., Pogue-Geile, M. F., Keshavan, M. S., & Cornelius, J. R. (2015). Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18-month feasibility trial. Schizophrenia Research, 161(2–3), 478–483. https://doi.org/10.1016/j.schres.2014.11.017
   PubMed Web of Science ®Google Scholar
• Edwards, J., Elkins, K., Hinton, M., Harrigan, S. M., Donovan, K., Athanasopoulos, O., & McGorry, P. D. (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta psychiatrica Scandinavica, 114(2), 109–117. https://doi.org/10.1111/j.1600-0447.2006.00783.x
   PubMed Web of Science ®Google Scholar
• Elison-Davies, S., Wardell, J. D., Quilty, L. C., Ward, J., & Davies, G. (2021). Examining correlates of cannabis users’ engagement with a digital intervention for substance use disorder: An observational study of clients in UK services delivering Breaking Free Online. Journal of Substance Abuse Treatment, 123, 108261. https://doi.org/10.1016/j.jsat.2020.108261
   PubMed Web of Science ®Google Scholar
• Gleeson, J. F. M., Cotton, S. M., Alvarez-Jimenez, M., Wade, D., Gee, D., Crisp, K., Pearce, T., Spiliotacopoulos, D., Newman, B., & McGorry, P. D. (2013). A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients: Outcome at 30-month follow-up. Schizophrenia Bulletin, 39(2), 436–448. https://doi.org/10.1093/schbul/sbr165
   PubMed Web of Science ®Google Scholar
• Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., Ware, M., Marmorstein, N., Cipriani, A., Dendukuri, N., & Mayo, N. (2019). Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis. JAMA Psychiatry, 76(4), 426–434. https://doi.org/10.1001/jamapsychiatry.2018.4500
   PubMed Web of Science ®Google Scholar
• González-Ortega, I., Echeburúa, E., García-Alocén, A., Vega, P., & González-Pinto, A. (2016). Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: Study protocol for a randomized controlled trial. Trials, 17, 372. https://doi.org/10.1186/s13063-016-1507-x
   PubMedGoogle Scholar
• Gustafson, D. H., Shaw, B. R., Isham, A., Baker, T., Boyle, M. G., & Levy, M. (2011). Explicating an evidence-based, theoretically informed, mobile technology-based system to improve outcomes for people in recovery for alcohol dependence. Substance Use & Misuse, 46(1), 96–111. https://doi.org/10.3109/10826084.2011.521413
   PubMed Web of Science ®Google Scholar
• Hall, W., & Degenhardt, L. (2008). Cannabis use and the risk of developing a psychotic disorder. World Psychiatry: Official Journal of the World Psychiatric Association (WPA), 7(2), 68–71. https://doi.org/10.1002/j.2051-5545.2008.tb00158.x
   PubMed Web of Science ®Google Scholar
• Hides, L., Baker, A., Norberg, M., Copeland, J., Quinn, C., Walter, Z., Leung, J., Stoyanov, S. R., & Kavanagh, D. (2020). A web-based program for cannabis use and psychotic experiences in young people (Keep it Real): Protocol for a randomized controlled trial. JMIR Research Protocols, 9(7), e15803. https://doi.org/10.2196/15803
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., & Sterne, J. A. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical Research ed.), 343, d5928. https://doi.org/10.1136/bmj.d5928
   PubMed Web of Science ®Google Scholar
• John, S. A., Walsh, J. L., & Weinhardt, L. S. (2017). The information-motivation-behavioral skills model revisited: A network-perspective structural equation model within a public sexually transmitted infection clinic sample of hazardous alcohol users. AIDS and Behavior, 21(4), 1208–1218. https://doi.org/10.1007/s10461-016-1446-2
   PubMed Web of Science ®Google Scholar
• Johnson, S., Rains, L. S., Marwaha, S., Strang, J., Craig, T., Weaver, T., McCrone, P., King, M., Fowler, D., Pilling, S., Marston, L., Omar, R. Z., Craig, M., Spencer, J., & Hinton, M. (2019). A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: The CIRCLE RCT. Health Technology Assessment (Winchester, England), 23(45), 1–108. https://doi.org/10.3310/hta23450
   Web of Science ®Google Scholar
• Kavanagh, D. J., Young, R., White, A., Saunders, J. B., Wallis, J., Shockley, N., Jenner, L., & Clair, A. (2004). A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review, 23(2), 151–155. https://doi.org/10.1080/09595230410001704127
   PubMed Web of Science ®Google Scholar
• Kay-Lambkin, F. J., Baker, A. L., Kelly, B., & Lewin, T. J. (2011). Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: A randomised controlled trial. The Medical Journal of Australia, 195(3), S44–S50. https://doi.org/10.5694/j.1326-5377.2011.tb03265.x
   PubMed Web of Science ®Google Scholar
• Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., & Carr, V. J. (2009). Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: A randomized controlled trial of clinical efficacy. Addiction (Abingdon, England), 104(3), 378–388. https://doi.org/10.1111/j.1360-0443.2008.02444.x
   PubMed Web of Science ®Google Scholar
• Kemp, R., Harris, A., Vurel, E., & Sitharthan, T. (2007). Stop Using Stuff: Trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists, 15(6), 490–493. https://doi.org/10.1080/10398560701439665
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. The American Journal of Orthopsychiatry, 66(1), 17–31. https://doi.org/10.1037/h0080151
   PubMed Web of Science ®Google Scholar
• Kristensen, K., & Cadenhead, K. S. (2007). Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Research, 151(1–2), 151–154. https://doi.org/10.1016/j.psychres.2006.10.001
   PubMed Web of Science ®Google Scholar
• Large, M., Sharma, S., Compton, M. T., Slade, T., & Nielssen, O. (2011). Cannabis use and earlier onset of psychosis: A systematic meta-analysis. Archives of General Psychiatry, 68(6), 555–561. https://doi.org/10.1001/archgenpsychiatry.2011.5
   PubMed Web of Science ®Google Scholar
• Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014). The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies. Psychological Medicine, 44(4), 797–810. https://doi.org/10.1017/S0033291713001438
   PubMed Web of Science ®Google Scholar
• Litvin, E. B., Abrantes, A. M., & Brown, R. A. (2013). Computer and mobile technology-based interventions for substance use disorders: An organizing framework. Addictive Behaviors, 38(3), 1747–1756. https://doi.org/10.1016/j.addbeh.2012.09.003
   PubMed Web of Science ®Google Scholar
• Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019). Cannabis and mental illness: A review. European Archives of Psychiatry and Clinical Neuroscience, 269(1), 107–120. https://doi.org/10.1007/s00406-018-0970-7
   PubMed Web of Science ®Google Scholar
• Macatee, R. J., Albanese, B. J., Okey, S. A., Afshar, K., Carr, M., Rosenthal, M. Z., Schmidt, N. B., & Cougle, J. R. (2021). Impact of a computerized intervention for high distress intolerance on cannabis use outcomes: A randomized controlled trial. Journal of Substance Abuse Treatment, 121, 108194. https://doi.org/10.1016/j.jsat.2020.108194
   PubMed Web of Science ®Google Scholar
• Madigan, K., Brennan, D., Lawlor, E., Turner, N., Kinsella, A., O'Connor, J. J., Russell, V., Waddington, J. L., & O’Callaghan, E. (2013). A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research, 143(1), 138–142. https://doi.org/10.1016/j.schres.2012.10.018
   PubMed Web of Science ®Google Scholar
• Marsch, L. A., & Dallery, J. (2012). Advances in the psychosocial treatment of addiction: The role of technology in the delivery of evidence-based psychosocial treatment. The Psychiatric Clinics of North America, 35(2), 481–493. https://doi.org/10.1016/j.psc.2012.03.009
   PubMed Web of Science ®Google Scholar
• Marsiglia, F. F., Kulis, S. S., Booth, J. M., Nuño-Gutierrez, B. L., & Robbins, D. E. (2015). Long-term effects of the keepin’ it REAL model program in Mexico: Substance use trajectories of Guadalajara middle school students. The Journal of Primary Prevention, 36(2), 93–104. https://doi.org/10.1007/s10935-014-0380-1
   PubMed Web of Science ®Google Scholar
• Mason, M. J. (2020). Depressive symptoms moderate cannabis use for young adults in a Text-Delivered randomized clinical trial for cannabis use disorder. Addictive Behaviors, 104, 106259. https://doi.org/10.1016/j.addbeh.2019.106259
   PubMed Web of Science ®Google Scholar
• Mustonen, A., Niemelä, S., Nordström, T., Murray, G. K., Mäki, P., Jääskeläinen, E., & Miettunen, J. (2018). Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis. The British Journal of Psychiatry: The Journal of Mental Science, 212(4), 227–233. https://doi.org/10.1192/bjp.2017.52
   PubMed Web of Science ®Google Scholar
• Nagel, T., & Thompson, C. (2010). The central role of Aboriginal families in motivational counselling: Family support and family ‘humbug’. Australian Indigenous Health Bulletin, 10(1), 1–17.http://healthbulletin.org.au/articles/the-central-role-of-aboriginal-families-in-motivational-counselling-family-support-and-family-%E2%80%98humbug%E2%80%99/
   Google Scholar
• Nagel, T., Robinson, G., Condon, J., & Trauer, T. (2009). Approach to treatment of mental illness and substance dependence in remote Indigenous communities: Results of a mixed methods study. Australian Journal of Rural Health, 17(4), 174–182. https://doi.org/10.1111/j.1440-1584.2009.01060.x
   PubMed Web of Science ®Google Scholar
• Nagel, T., Robinson, G., Trauer, T., & Condon, J. (2008). An approach to treating depressive and psychotic illness in Indigenous communities. Australian Journal of Primary Health, 14(1), 17–24. https://doi.org/10.1071/PY08003
   Web of Science ®Google Scholar
• Olmos, A., Tirado-Muñoz, J., Farré, M., & Torrens, M. (2018). The efficacy of computerized interventions to reduce cannabis use: A systematic review and meta-analysis. Addictive Behaviors, 79, 52–60. https://doi.org/10.1016/j.addbeh.2017.11.045
   PubMed Web of Science ®Google Scholar
• Onaemo, V. N., Fawehinmi, T. O., & D’Arcy, C. (2021). Comorbid cannabis use disorder with major depression and generalized anxiety disorder: A systematic review with meta-analysis of nationally representative epidemiological surveys. Journal of Affective Disorders, 281, 467–475. https://doi.org/10.1016/j.jad.2020.12.043
   PubMed Web of Science ®Google Scholar
• Padwa, H., Guerrero, E. G., Braslow, J. T., & Fenwick, K. M. (2015). Barriers to serving clients with co-occurring disorders in a transformed mental health system. Psychiatric Services (Washington, D.C.), 66(5), 547–550. https://doi.org/10.1176/appi.ps.201400190
   PubMed Web of Science ®Google Scholar
• Shoptaw, S., Montgomery, B., Williams, C. T., El-Bassel, N., Aramrattana, A., Metsch, L., Metzger, D. S., Kuo, I., Bastos, F. I., & Strathdee, S. A. (2013). Not just the needle: The state of HIV-prevention science among substance users and future directions. JAIDS Journal of Acquired Immune Deficiency Syndromes, 63(Supplement 2), S174–S178. https://doi.org/10.1097/QAI.0b013e3182987028
   PubMedGoogle Scholar
• Smeerdijk, M., Keet, R., de Haan, L., Barrowclough, C., Linszen, D., & Schippers, G. (2014). Feasibility of teaching motivational interviewing to parents of young adults with recent-onset schizophrenia and co-occurring cannabis use. Journal of Substance Abuse Treatment, 46(3), 340–345. https://doi.org/10.1016/j.jsat.2013.09.006
   PubMed Web of Science ®Google Scholar
• Sugarman, D. E., Campbell, A. N. C., Iles, B. R., & Greenfield, S. F. (2017). Technology-based interventions for substance use and comorbid disorders: An examination of the emerging literature. Harvard Review of Psychiatry, 25(3), 123–134. https://doi.org/10.1097/HRP.0000000000000148
   PubMed Web of Science ®Google Scholar
• Tatar, O., Abdel-Baki, A., Tra, C., Mongeau-Pérusse, V., Arruda, N., Kaur, N., Landry, V., Coronado-Montoya, S., & Jutras-Aswad, D. (2021). Technology-based psychological interventions for young adults with early psychosis and cannabis use disorder: Qualitative study of patient and clinician perspectives. JMIR Formative Research, 5(4), e26562. https://doi.org/10.2196/26562
   PubMedGoogle Scholar
• Tatar, O., Bastien, G., Abdel-Baki, A., Huỳnh, C., & Jutras-Aswad, D. (2020). A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis. Psychiatry Research, 288, 112940. https://doi.org/10.1016/j.psychres.2020.112940
   PubMed Web of Science ®Google Scholar
• Thornton, L. K., Baker, A. L., Lewin, T. J., Kay-Lambkin, F. J., Kavanagh, D., Richmond, R., Kelly, B., & Johnson, M. P. (2012). Reasons for substance use among people with mental disorders. Addictive Behaviors, 37(4), 427–434. https://doi.org/10.1016/j.addbeh.2011.11.039
   PubMed Web of Science ®Google Scholar
• Whiteley, L., Haubrick, K. K., Arnold, T., Craker, L., Olsen, E., Hershkowitz, D., Maj, S., & Brown, L. K. (2021). Motivators for cannabis use among young adults in outpatient psychiatric care: A qualitative study. Journal of Drug Issues, 51(3), 590–604. https://doi.org/10.1177/00220426211002125
   Web of Science ®Google Scholar
• Woody, G. (1996). The challenge of dual diagnosis. Alcohol Health and Research World, 20(2), 76–80.https://www.ncbi.nlm.nih.gov/pubmed/31798155
   PubMedGoogle Scholar